You are here

UMass Memorial Medical Center Honored with Gold Quality Achievement Award for AFib Care

WORCESTER, Mass. – UMass Memorial Medical Center is the proud recipient of the 2017 American Heart Association’s Get with The Guidelines - Atrial Fibrillation (AFib) Gold Quality Achievement Award. It’s one of only two hospitals in Massachusetts to have earned this designation for its atrial fibrillation program.

Get With The Guidelines-AFib was developed to assist health care professionals to provide the most up-to-date, research-based guidelines for patients with atrial fibrillation, an irregular heartbeat that can lead to stroke and other complications.

The award recognizes the implementation of specific quality improvement measures outlined by the American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines for the management of patients with atrial fibrillation.

UMass Memorial Medical Center earned the Gold Award by reaching an aggressive goal of treating atrial fibrillation patients with 85 percent or higher compliance to core standard levels of care - as outlined by the American Heart Association/American Stroke Association - for 24 consecutive months. Quality achievement measures include proper use of medications and aggressive risk reduction therapies such as safe anticoagulants to prevent stroke. Also evaluated is the usage of medications to stabilize the heart rate and rhythm and other medications needed to treat additional heart diseases. Before they are discharged, patients receive education on managing their condition and stroke risk, counseling if needed, and plans on follow-up care.

“This Gold Quality Achievement Award assures our patients and community members that when they come to UMass Memorial Medical Center they are getting A+ level care,” Dave McManus, M.D., director, Atrial Fibrillation Program. “Our team of caregivers is dedicated to improving the quality of care for our patients with atrial fibrillation. Implementing the American Heart Association’s Get with The Guidelines-AFib program helps us accomplish this goal by tracking and measuring our success.”

“We are pleased to recognize UMass Memorial Medical Center for their commitment to atrial fibrillation care,” said Paul Heidenreich, MD, MS, national chairman of the Get with The Guidelines Steering Committee and professor of medicine at Stanford University. “Research has shown there are benefits to patients who are treated at hospitals that have adopted the Get with The Guidelines program. Get with The Guidelines research has demonstrated the impact of lowering 30-day readmissions and reducing mortality rates.”

Per the American Heart Association, more than 2.7 million adults suffer from atrial fibrillation. The condition accounts for about one-third of hospitalizations for cardiac rhythm disturbance and is associated with a five-fold increase risk of stroke. Proper treatment of atrial fibrillation can reduce these risks.


About UMass Memorial Health Care

UMass Memorial Health Care is the largest not-for-profit health care system in Central Massachusetts with more than 12,900 employees and 1,670 physicians, many of whom are members of UMass Memorial Medical Group. Our member hospitals and entities include Clinton Hospital, HealthAlliance Hospital, Marlborough Hospital, UMass Memorial Medical Center and Community Healthlink, our behavioral health agency. With our teaching and research partner, the University of Massachusetts Medical School, our extensive primary care network and our cancer, diabetes, heart and vascular, and musculoskeletal programs, UMass Memorial delivers safe, high-quality and compassionate care.

Call 855-UMASS-MD (855-862-7763) for all your health care needs. Visit

About Get with The Guidelines

Get with The Guidelines® is the American Heart Association/American Stroke Association’s hospital-based quality improvement program provides hospitals with the latest research-based guidelines. Developed with the goal of saving lives and hastening recovery, Get with The Guidelines has touched the lives of more than six million patients since 2001. For more information, visit